Evidence map›Paper›PMID 23243310›Full record

ArticleThe Journal of biological chemistry2013

Transforming growth factor-β directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas.

Lindsay C Spender, Matthew J Carter, Darren I O'Brien, Louise J Clark, Jian Yu, Ewa M Michalak, Lina Happo, Mark S Cragg, Gareth J Inman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Combined BCL-2 and PI3K/AKT Pathway Inhibition inInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A Systematic Review of miR-29 in Cancer.Molecular therapy oncolytics · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 4 countries.

Lindsay C SpenderDivision of Cancer Research, Medical Research Institute, Jacqui Wood Cancer Centre, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom.
Matthew J Carter
Darren I O'Brien
Louise J Clark
Jian Yu
Ewa M Michalak
Lina Happo
Mark S Cragg
Gareth J Inman
University of Dundee · GBCancer Research UK Scotland Institute · GBSouthampton General Hospital · GBSouthern General Hospital · GBThe Netherlands Cancer Institute · NLUniversity of Melbourne · AUUniversity of Pittsburgh · USUniversity of Southampton · GB

Funding

Intestinal Stem Cell Survival and Renewal Coordinately Regulated by PUMA and p21U01DK085570 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YU, JIAN · 2009 to 2014
$2.2M
Role of PUMA in EGFR targeted therapy in HNSCCR01CA129829 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YU, JIAN · 2008 to 2012
$1.6M
Medical Research CouncilNCI NIH HHS CA129829NCI NIH HHS R01 CA129829NIDDK NIH HHS U01 DK085570NIDDK NIH HHS U01-DK085570Worldwide Cancer Research 11-0788
6 · The paper itself

Abstract

c-Myc transformed human Burkitt's lymphoma (BL) cells are highly sensitive to TGF-β-induced apoptosis. Previously we demonstrated that TGF-β-mediated cell death in BL cells is regulated via the mitochondrial intrinsic apoptosis pathway, which is dependent on the activation of BAX and/or BAK. TGF-β directly induces transcription of the BH3-only protein BIK and represses expression of the pro-survival factor BCL-X(L) but has no effect on the direct BAX/BAK "activators" BIM or BID (tBID). Here we show that TGF-β induces the BH3-only activator PUMA to aid induction of the intrinsic cell death pathway. TGF-β also induced PUMA in normal germinal center CD77-positive centroblasts isolated from human tonsil tissue. PUMA was a direct TGF-β target gene in B-cells, and we identify a putative Smad-binding region within the human PUMA promoter that recruits Smad3 and Smad4 in cells in response to TGF-β signaling. Constitutive activity of the isolated Smad-binding region in luciferase reporter assays was dependent on Smad consensus sequences and was partially dependent on endogenous TGF-β signaling and Smad4. Knockdown of PUMA in BL cells using lentiviral shRNA resulted in slower kinetics of the TGF-β-mediated apoptotic response. Analysis of Eμ-Myc cell lines demonstrated that c-myc-driven murine lymphomas are also sensitive to TGF-β-mediated apoptosis. Moreover, Puma(-/-) Eμ-Myc lines demonstrated significantly delayed kinetics of the apoptotic response when compared with wild type lymphomas. TGF-β therefore induces a polygenic response in Myc-driven lymphomas involving transcription of PUMA, which is necessary for the rapid induction of cell death.

Indexed as

ApoptosisGene Expression Regulation, NeoplasticAnimalsApoptosis Regulatory ProteinsCell LineCell SurvivalHEK293 CellsHumansKineticsLymphomaLymphoma, B-CellMicePromoter Regions, GeneticProto-Oncogene ProteinsProto-Oncogene Proteins c-mycSignal TransductionApoptosis Regulatory ProteinsBBC3 protein, humanProto-Oncogene ProteinsProto-Oncogene Proteins c-mycTP53 protein, humanTransforming Growth Factor betaTumor Suppressor Protein p53

Identifiers

PMID23243310
PMCPMC3576124
OpenAlexW2002979776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.